U.S. Markets closed

CVS to profit from ObamaCare

The gov't overhaul of the U.S. health care system should drive more business to drugstore chain CVS Caremark (CVS), the company said, as it raised its 2013 EPS outlook to $3.84-$3.98, above estimates of $3.82. CVS also lifted its quarterly dividend 38% to 22.5 cents a share. It expects Q1 sales to fall 2.5%-4% vs. last year due to a shift to cheaper generic drugs. CVS climbed 2% to 48.50.